Skip to content

Clinical trials

Completed Phase 2 Sleep Initiation and Maintenance Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Initiation and Maintenance Disorders Phase: Phase 2 Status: Completed Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20032
20044
20055
200612
20077
20088
20094
20101
20113
20122
20132
20141
20155
20162
20173
20181
20193
20204
20211
20225
20236
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Takeda6
Idorsia Pharmaceuticals Ltd.4
Neurim Pharmaceuticals Ltd.3
Stanford University3
Arena Pharmaceuticals2
Eli Lilly and Company2
Evotec Neurosciences GmbH2
Janssen Research & Development, LLC2
Johns Hopkins University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Initiation and Maintenance Disorders92
Anxiety Disorders6
Sleep Wake Disorders6
Parasomnias4
Fatigue3
Major Depressive Disorder3
Pain3
Sleep Deprivation3
Stress Disorders, Post-Traumatic3
Autism Spectrum Disorder2

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.